--- title: 'Molecular Supervisor at Universal DX' canonical: 'https://feeny.ai/job/molecular-supervisor-universal-dx-dallas-dhmgsx79f4kt' type: 'job' last_seen: '2026-09-09' --- # Molecular Supervisor at Universal DX - **Company:** Universal DX - **Location:** Dallas, TX - **Posted:** 2026-08-13 - **Last confirmed live:** 2026-09-09 - **Apply:** https://www.universaldx.com/careers?gh_jid=4883956101#grnhse_app ## Job description About our Company: Universal DX, Inc. is an international Company with a highly experienced team focused on cracking cancer’s code. Through our multi-omics and bioinformatics models, we have figured out how to read the disease’s signals in blood with high accuracy to detect cancer in its earliest stages. Starting with a colorectal cancer screening liquid biopsy test, we are building a multi-cancer platform that can identify the unique DNA regions associated with different types of cancers. The Opportunity: Universal Diagnostics (UDx) is seeking a Molecular Supervisor to join our Lab Operations Team in the Dallas-Fort Worth, TX area. In this role, you will oversee day-to-day molecular laboratory operations while providing leadership and operational oversight for workflow execution, study support, and laboratory personnel. You will support laboratory staffing, scheduling, operational readiness, and execution activities while helping ensure workflows are performed efficiently and in accordance with established procedures, quality standards, and study timelines. This position will work closely with cross-functional teams including assay development, automation, bioinformatics, quality, and laboratory operations to support scaling of the UDx Signal-C assay. How you’ll contribute: - Oversee daily molecular laboratory operations and study execution activities - Supervise and support Molecular Technologists and laboratory staff during workflow execution - Coordinate laboratory staffing, scheduling, and operational workflow planning activities - Perform and support end-to-end NGS workflows including plasma processing, cfDNA extraction, library preparation, amplification, and sequencing support activities - Ensure laboratory reagents, consumables, equipment, and resources are available to support execution timelines - Monitor workflow performance and assist with identifying operational risks, bottlenecks, and process improvement opportunities - Troubleshoot workflow, operational, and equipment-related issues during study execution - Maintain accurate and complete documentation in LIMS and laboratory records - Ensure workflows are performed according to SOPs, batch records, and laboratory quality requirements - Support onboarding, training, and performance development of Molecular Technologists and laboratory staff - Collaborate with cross-functional teams to support laboratory execution and operational readiness - Support laboratory quality initiatives, deviation investigations, corrective actions, and inspection readiness activities - Adhere to laboratory safety policies and quality standards What you’ll bring: - Bachelor’s degree in biology/chemistry or a related field, with hands-on experience in a molecular laboratory - Minimum 3–5 years of experience supporting NGS laboratory operations, workflow coordination, staff training, and study execution activities - Strong leadership, organizational, troubleshooting, and workflow coordination skills in a fast-paced laboratory environment - Experience supporting laboratory staffing, scheduling, performance reviews, training, and operational execution activities within molecular laboratory workflows - Proficiency with Microsoft Office (Excel, Word, Outlook) - Experience working in a CLIA or CAP high-complexity laboratory required What we´ll offer: We’re proud to offer exceptional corporate benefits which include: - 22 days of PTO with the possibility to carry over 10 days to the following year. - Company Holidays, plus your Birthday off! - Company-sponsored benefit plans, including medical, dental, and vision insurance plus life, STD, and LTD coverage, and 401(k). - Flexible work schedule - And more to come! Why Now? This is an exciting time to be at Universal DX. We are growing rapidly and starting our US operations by building up our team, starting our lab and business operations, and establishing strategic partnerships. We are looking for passionate changemakers to be a part of our journey in this expansive time for us. ## About Universal DX ## Company Overview - **One-liner**: Universal DX develops minimally-invasive, blood-based liquid biopsy tests for early cancer detection, starting with colorectal cancer screening. - **Entity Type**: Private (Series unknown; last known venture round in 2018, recent grant and EIB financing) - **Headquarters**: Sevilla, Spain (with offices in Madrid, Spain; Dallas, Texas, USA; and Ljubljana, Slovenia) - **Founded**: 2012 - **Founders**: Juan Martinez-Barea (Founder and Executive President) ## Core Business - **Primary industry**: Biotechnology / Diagnostics (liquid biopsy, early cancer detection) - **Target customers**: Healthcare providers, hospitals, clinical laboratories, and patients (B2B and B2C via screening programs) - **Mission**: “A future where cancer is curable” – by detecting cancer in its earliest stages when treatment is more effective and survival rates are high. ## Products & Services - **Signal‑C**: A blood‑based colorectal cancer screening test that detects cancer and advanced adenomas with 92% sensitivity and 94% specificity. It uses proprietary methylation markers and a machine‑learning algorithm to analyze a simple blood sample. The test is designed to be processed in standard reference laboratories and is intended for FDA approval and subsequent distribution through Quest Diagnostics. - **Cancer Platform (in development)**: A multi‑cancer platform that aims to detect multiple cancer types (prostate, liver, pancreatic, lung, breast, etc.) through a single blood draw, leveraging the same multi‑omics, computational biology approach. ## Market Standing - **Valuation**: Not publicly disclosed - **Key Metric**: Total funding of **$186.1 million** (as of early 2026, including a €20 million EIB loan in Feb 2025 and a $30 million grant in Jan 2026). Annual revenue is reported at **$4.3 million** (LinkedIn estimate). - **Notable Investors/Partners**: Quest Diagnostics (strategic collaboration for US commercialization), European Investment Bank (EIB), Innvierte (CDTI investment program). Clinical partners network of >100 hospitals across the US and Europe. - **Growth Signals**: - Over 14,000 samples collected from clinical studies. - Active clinical collaborations with more than 100 gastrointestinal teams. - Recent patent filings for pancreatic cancer detection methods. - Headcount of 105 employees (as of mid‑2026), with a monthly growth rate of +0.8%. - Presence in 6 countries (US, Spain, Slovenia, New Zealand, Netherlands, Italy). - 22,423 LinkedIn followers with +1.8% monthly growth. ## Competitive Advantages - **Proprietary multi‑omics platform**: Combines epigenomics, methylomics, and machine learning to “read” cancer’s signal in blood, enabling a single‑test, multi‑cancer approach. - **High accuracy for colorectal cancer**: Signal‑C shows 92% sensitivity and 94% specificity, competitive with leading stool‑based tests but with a simpler blood draw. - **Strategic partnership with Quest Diagnostics**: Once FDA‑approved, Signal‑C will be distributed through Quest’s national network, dramatically accelerating adoption and reimbursement. - **Strong clinical validation network**: Over 100 partner hospitals in the US and Europe, providing real‑world data and regulatory credibility. ## Strategic Focus - **FDA approval and commercialization**: The immediate priority is obtaining FDA approval for Signal‑C and launching it through the Quest Diagnostics partnership to capture a share of the US colorectal cancer screening market. - **Expanding the multi‑cancer platform**: Developing blood tests for other high‑burden cancers (pancreatic, liver, lung, breast) to eventually offer a single‑draw screening for >50% of new cancer cases. - **Strengthening the evidence base**: Continuing to present at major conferences (AACR, ASCO) and publish peer‑reviewed studies to support regulatory submissions and clinical uptake. ## Why Work Here - **Mission‑driven culture**: The company’s explicit goal is “making cancer a curable disease by detecting it earlier” – a compelling purpose that attracts talent passionate about healthcare impact. - **Flexible work environment**: Offers a flexible work schedule, remote work opportunities, and a “free day on your birthday.” Employees can also buy extra vacation days. - **Competitive perks**: Fair salaries, optional health insurance, parking incentives, free café amenities at office locations, and a healthy work environment. - **International team**: Offices in Spain (Sevilla, Madrid), the US (Dallas, TX), and Slovenia (Ljubljana). Workforce is split roughly 39% US, 39% Spain, with smaller teams in other countries. - **Open positions** (as of June 2026): 6 active roles including Lab Ops Technical Lead, IVD Scientist, Director of IT, RA Technical Writer, Senior Biostatistician, and Software Development Engineer in Test. (Note: the company’s own careers page may show different availability; LinkedIn lists 6 open positions.) - **Engineering & R&D focus**: 25% of employees are in Research, 17% in Technical roles, with a strong emphasis on data science, biostatistics, and software engineering. - **Talent sources**: Employees often come from leading oncology diagnostics firms (Exact Sciences, Guardant Health, Freenome, Resolution Bioscience), indicating a high‑caliber peer group. ## Sources 1. [universaldx.com](https://www.universaldx.com/) 2. [universaldx.com/about-us](https://www.universaldx.com/about-us) 3. [universaldx.com/careers](https://www.universaldx.com/careers) 4. [universaldx.com/contact](https://www.universaldx.com/contact) 5. [linkedin.com/company/universal-diagnostics-sa](https://www.linkedin.com/company/universal-diagnostics-sa/) ## Other roles at Universal DX - [Technical Writer, Product Development](https://feeny.ai/job/technical-writer-product-development-universal-dx-united-states-p0zw2jgwt4wc) — United States - [Patent Agent (Oncology & Molecular Diagnostics)](https://feeny.ai/job/patent-agent-oncology-molecular-diagnostics-universal-dx-united-states-vs0xezfvcamd) — United States - [Principal NGS Automation Architect](https://feeny.ai/job/principal-ngs-automation-architect-universal-dx-united-states-n1s93d8hf90d) — United States